Conquering CMV Viremia with CMV immunoglobulin, triumph in Renal Transplant Patients: A Case Series
DOI:
https://doi.org/10.38106/LMRJ.2024.6.3-09Keywords:
infectionsAbstract
This case series offers the successful management of cytomegalovirus (CMV) viremia in patients who developed CMV infection post renal transplantation. The patients have been treated with three doses of CMV immunoglobulin and ganciclovir for 21 days. The CMV load in each affected person extensively reduced after treatment, indicating the effectiveness of this regimen in coping with CMV viremia in resource constrains setting
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Muhammad Tassaduq Khan, Sidra Rashid, Rashid bin Hamid, Naranjan Lal, Syed Hasan Farooq, Syeda Mehak Zahra
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: Open access journal copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
